A Pilot Study of Salmon Protein Hydrolysate (ProGo(®)) Supplementation to Assess Its Impact on Hematologic, Integumentary and Metabolic Health.

Currie C, Myklebust TÅ, Bjerknes C, Framroze B

Open source

DOI
10.3390/biomedicines14081663
Published
2026 Jul 24
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14081663,
  title = {A Pilot Study of Salmon Protein Hydrolysate (ProGo(®)) Supplementation to Assess Its Impact on Hematologic, Integumentary and Metabolic Health.},
  author = {Currie C and Myklebust TÅ and Bjerknes C and Framroze B},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14081663},
  url = {https://doi.org/10.3390/biomedicines14081663}
}

RIS

TY  - JOUR
TI  - A Pilot Study of Salmon Protein Hydrolysate (ProGo(®)) Supplementation to Assess Its Impact on Hematologic, Integumentary and Metabolic Health.
AU  - Currie C
AU  - Myklebust TÅ
AU  - Bjerknes C
AU  - Framroze B
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14081663
UR  - https://doi.org/10.3390/biomedicines14081663
ER  - 

APA

C, C., TÅ, M., C, B., & B, F. (2026). A Pilot Study of Salmon Protein Hydrolysate (ProGo(®)) Supplementation to Assess Its Impact on Hematologic, Integumentary and Metabolic Health.. Biomedicines. https://doi.org/10.3390/biomedicines14081663

Source records